高血糖症（Hyperglycemia）：グローバル臨床試験レビュー（2014年上半期）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Hyperglycemia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Hyperglycemia to Metabolic Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Hyperglycemia to Metabolic Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Hyperglycemia 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Hyperglycemia Therapeutics Clinical Trials 30
Prominent Drugs 32
Latest Clinical Trials News on Hyperglycemia 33
Dec 06, 2011: Study Shows Combination Insulin Degludec/Insulin Aspart Significantly Reduced Hypoglycaemia In Type 1 And Type 2 Diabetes Patients 33
Nov 15, 2011: PhaseBio Announces Positive Results From Phase I/IIa Trial Of Glymera For Treatment Of Hyperglycemia In Patients With Type 2 Diabetes 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Sanofi 34
Clinical Trial Overview of Sanofi 34
Novo A/S 35
Clinical Trial Overview of Novo A/S 35
Eli Lilly and Company 36
Clinical Trial Overview of Eli Lilly and Company 36
Novartis AG 37
Clinical Trial Overview of Novartis AG 37
Children’s Healthcare of Atlanta Inc. 38
Clinical Trial Overview of Children’s Healthcare of Atlanta Inc. 38
AstraZeneca PLC 39
Clinical Trial Overview of AstraZeneca PLC 39
Vegenat, S.A. 40
Clinical Trial Overview of Vegenat, S.A. 40
Boehringer Ingelheim GmbH 41
Clinical Trial Overview of Boehringer Ingelheim GmbH 41
BIOGLANE, S.L.N.E. 42
Clinical Trial Overview of BIOGLANE, S.L.N.E. 42
Astellas Pharma Inc. 43
Clinical Trial Overview of Astellas Pharma Inc. 43
Clinical Trial Overview of Top Institutes / Government 44
Emory University 44
Clinical Trial Overview of Emory University 44
Karolinska Institutet 45
Clinical Trial Overview of Karolinska Institutet 45
Northwestern University 46
Clinical Trial Overview of Northwestern University 46
Kansas State University 47
Clinical Trial Overview of Kansas State University 47
University of Toronto 48
Clinical Trial Overview of University of Toronto 48
Mayo Clinic 49
Clinical Trial Overview of Mayo Clinic 49
U.S. Department of Veterans Affairs 50
Clinical Trial Overview of U.S. Department of Veterans Affairs 50
National Center for Research Resources 51
Clinical Trial Overview of National Center for Research Resources 51
Hadassah Medical Organization 52
Clinical Trial Overview of Hadassah Medical Organization 52
The Ohio State University 53
Clinical Trial Overview of The Ohio State University 53
Five Key Clinical Profiles 54
Appendix 111
Abbreviations 111
Definitions 111
Research Methodology 112
Secondary Research 112
About GlobalData 113
Contact Us 113
Disclaimer 113
Source 113